A cluster-randomized clinical trial finds that adoption of onsite polymerase chain reaction (PCR) testing for COVID-19, ...

Speed and precision are two of the most vital considerations when it comes to patient care in the high-stakes environment of the Emergency Department (ED). Thus, swift decision-making and accurate ...

Point of care devices within the healthcare system can aid in improving diagnoses as well as the control of diseases through monitoring. These devices can include glucose monitors that only require a ...

Point-of-care testing is disrupting global diagnostics, creating opportunities for companies such as Lumos Diagnostics ...

In a study published today in Biofunctional Materials, Prof. Dr. Haidar, Founder and CEO of BioMAT’X I+D+I LABs in Santiago, Chile, explores a new era in healthcare diagnostics driven by ...

The use of point-of-care respiratory multiplex polymerase chain reaction (POC-RMPCR) in nursing homes did not affect the ...

Integrating a rapid point-of-care polymerase chain reaction (PCR) testing for sexually transmitted infections (STIs) in the emergency department (ED) reduced the length of stay of patients by 76 ...

QuidelOrtho (QDEL) stock is in focus as the company weighs selling its point-of-care testing unit for ~$1.5B to cut debt.

A novel nanobody-based immunosensor, designed to function stably in undiluted biological fluids and harsh conditions, has been developed. Their innovative design leverages BRET -- bioluminescence ...

Diagnostics firm QuidelOrtho Corp is looking to sell its point-of-care testing unit at a valuation of $1.5 billion, the ...

QuidelOrtho is in talks to sell its point-of-care testing unit behind the rapid antigen tests for Covid and flu, Financial ...